The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Share News (CNKS)

  • There is currently no data for CNKS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cenkos Securities Swings To Interim Profit On Corporate Activity Boost

Fri, 02nd Oct 2020 10:16

(Alliance News) - Cenkos Securities PLC on Friday said it swung to profit in the first half of 2020 with increased corporate activity among clients during the Covid-19 pandemic.

Shares in Cenkos were up 2.6% at 46.15 pence in London in morning trading.

The London-based broker posted a GBP590,000 pretax profit for the six months ended June 30, swinging from a GBP201,000 loss a year before.

This stemmed from a 22% rise in revenue to GBP12.9 million from GBP10.6 million, as clients were driven to raise funds to cope with the pandemic and its associated lockdown measures or, conversely, to take advantage of new opportunities it presented.

"Swift action and our flexible operating model meant we have been fully operational throughout this time and therefore able to focus on our clients' needs and assist them through this period. Indeed, the second quarter of 2020 saw a further increase in corporate activity, such that secondary funds raised on AIM were more than double that raised in the first quarter," Chief Executive Jim Durkin noted.

Corporate finance fees rose 48% to GBP9.2 million as corporate activity increased, with companies raising funds to shore up balance sheets amid the economic downturn. Cenkos's focus on growth companies also meant that clients were raising funds for acquisitions and expansion.

However, Cenkos halved its interim dividend to 1.0p per share from 2.0p per share.

Durkin said: "Since the end of the period, we have completed several equity fundraisings for our clients. Although our current pipeline is encouraging and we continue to win new clients, we recognise that the prevalence of both the virus and measures taken to contain it, pose a continuing risk to the health of the economy and the financial markets.

"The restructuring programme started in 2019, has resulted in a significantly lower cost base going forward which, combined with the strength of Cenkos balance sheet and a rejuvenated strategic focus, means the company is well placed to face the challenges ahead. The second half of the current financial year has begun with energy and purpose at Cenkos, despite the ongoing macro challenges presented by the ongoing coronavirus."

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
16 Dec 2015 12:40

DIRECTOR DEALINGS: Cenkos Chief Executive Durkin Adds To Stake

Read more
9 Dec 2015 18:00

DIRECTOR DEALINGS: Cenkos Says Durkin And Hodges Add To Holdings

Read more
8 Dec 2015 12:11

LONDON MARKET MIDDAY: Wary Eyes On BHP, Rio As Anglo Suspends Dividend

Read more
8 Dec 2015 10:40

WINNERS & LOSERS SUMMARY: Anglo American Sold As It Suspends Dividend

Read more
8 Dec 2015 09:04

Cenkos says not being investigated by SFO

(ShareCast News) - Stockbroker Cenkos Securities rallied after saying it was not being investigated by the Serious Fraud Office. The statement followed a report in the Sunday Times suggesting that the company had handed over a cache of documents to the SFO in relation to Watchstone Group, formerly k

Read more
8 Dec 2015 08:33

LONDON MARKET OPEN: Miners And Oil Firms Down As Anglo Gets "Radical"

Read more
8 Dec 2015 07:59

Cenkos Securities Says It Is Not Subject To SFO Investigation

Read more
25 Nov 2015 17:08

Cenkos To Buy Back 4.5 Million Shares Under GBP8 Million Tender Offer

Read more
30 Oct 2015 08:21

Cenkos Gets Started On GBP8.0 Million Return To Shareholders

Read more
22 Sep 2015 08:47

Cenkos Securities Profit Down On Lower AIM Activity In First Half

Read more
26 Jun 2015 10:34

Essenden Agrees To GBP40.1 Million Takeover Offer From Harwood Capital

Read more
15 Jun 2015 16:45

U.S. biotech company Evofem eyes London listing -sources

LONDON, June 15 (Reuters) - Biotech company Evofem is working with U.S. bank JP Morgan and British broker Cenkos on a London stock market listing aimed at raising about $200 million, three sources familiar with the matter said on Monday. San Diego-based Evofem, which specialises in women's

Read more
12 May 2015 08:25

Cenkos Securities Chairman Says Pipeline Remains Encouraging

Read more
7 May 2015 09:48

Verseon, Curtis Banks And MayAir Début On AIM (ALLIPO)

Read more
1 May 2015 11:28

DIRECTOR DEALINGS SUMMARY: Sweett Group Directors Buy 232,000 Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.